Treatment with infliximab in patients with Crohn disease; experience in 132 patients
Smits, S.R.J.G.; Heijman, J.A.; van Dullemen, H.M.; Rutten, W.J.M.J.; Annemans, L.; Brouwers, J.R.B.J.; Postma, M.J.
Nederlands Tijdschrift Voor Geneeskunde 146(39): 1857-8; author reply 1858
2002
ISSN/ISBN: 0028-2162 PMID: 12382373 Document Number: 542823
Document emailed within 1 workday
Related Documents
Luna-Chadid, M.; Pérez Calle, J.L.; Mendoza, J.L.; Vera, M.I.; Bermejo, A.F.; Sánchez, F.; López San Román, A.; Froilán, C.; González-Lara, V.; García-Paredes, J.; Fernández-Blanco, I.; Abreu, L.; Casis, B.; Solís Herruzo, J.A.; Gisbert, J.P.; Maté Jiménez, J. 2004: Predictors of response to infliximab in patients with fistulizing Crohn's disease Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 96(6): 379-81; 382-4Cadahia, V.; García-Carbonero, A.; Vivas, S.; Fuentes, D.; Niño, P.; Rebollo, P.; Rodrigo, L. 2004: Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 96(6): 369-74; 374-8
Herman, R.; Sładek, M.łg.; Pieczarkowski, S.ła.; Dumnicka, P.; Fyderek, K. 2017: Is mean platelet volume a good predictor of sustained response to one year infliximab therapy in pediatric patients with Crohn's disease? Folia Medica Cracoviensia 57(2): 63-71
Zheng, J.-J.; Wang, Y.-M.; Zhu, F.; Gu, W.; Xing, Y.-C.; Zhou, C.-L.; Shen, B.-W. 2009: A study of efficiacy of infliximab treatment for Crohn's disease Zhonghua Nei Ke Za Zhi 48(11): 922-925
Olfa, H.; Aroua, G.; Wissem, M.; Wafa, B.M.; Hichem, L.; Nabil, B.C.èn.; Fethia, B.; Leila, S. 2014: Fulminant acute hepatitis B after infliximab treatment in Crohn's disease La Tunisie Medicale 92(5): 349-350
Auer, I.O.; Röder, A.; Mittelstaedt, A. 1985: Treatment of Crohn's disease using Colibiogen. Cellular reactions of the immune system in patients with Crohn's disease Fortschritte der Medizin 103(46): 1076-1080
Yang, B.-l.; Lin, Q.; Chen, H.-j.; Sun, G.-d.; Zhu, P.; Chen, Y.-q.; Gu, Y.-f. 2013: Efficacy of infliximab combined with surgery in the treatment of perianal fistulizing Crohn disease Zhonghua Wei Chang Wai Ke Za Zhi 16(4): 323-327
Famenini, S.; Wu, J.J. 2013: Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases Journal of Drugs in Dermatology: Jdd 12(8): 939-943
Sinagra, E.; Orlando, A.; Renna, S.; Criscuoli, V.; La Seta, F.; Olivo, M.; Ciofalo, M.; Cottone, M. 2013: Is really megacolon a contraindication to infliximab in Crohn's disease? Acta Gastro-Enterologica Belgica 76(4): 442-444
Arslan, S.; Kav, T.; Besisik, F.; Kaymakoglu, S.; Pinarbasi, B.; Tözün, N.; Hamzaoglu, Hülya.Over.; Duman, D.; Ulker, A.; Parlak, E.; Palabiyikoglu, M.; Dökmeci, Aülkadir. 2003: Clinical outcome of Crohn's disease treated with infliximab Hepato-Gastroenterology 50(52): 952-956
Ferkolj, I.; Ihan, A.; Markovic, S. 2005: CD19+ in intestinal mucosa predict the response to infliximab in Crohn's disease Hepato-Gastroenterology 52(64): 1128-1133
Bury, T.F.; van Vroonhoven, T.J.; Stuifbergen, W.N. 1988: The role of surgical intervention in the treatment of patients with Crohn's disease Nederlands Tijdschrift Voor Geneeskunde 132(53): 2414-2417
Borruel, N.; Castro, J.; Riestra, S.; Costi, Mía.; Casellas, F. 2014: Treatment preferences of patients with Crohn's disease: Development of the IMPLICA questionnaire Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 106(6): 372-380
Sacco, R.; Bertini, M.; Bresci, G.; Romano, A.; Altomare, E.; Capria, A. 2010: Entecavir for hepatitis B virus flare treatment in patients with Crohn's disease Hepato-Gastroenterology 57(98): 242-245
Lukina, G.V.; Sigidin, I.A.; Nasonov, E.L. 2009: Clinical experience with infliximab administration in patients with rheumatoid arthritis (according to Russian register data) Terapevticheskii Arkhiv 81(8): 65-69
Bedrna, J.; Konecný, B. 1989: Personal experience with the treatment of Crohn's disease Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 68(8-9): 529-535
Aleksandrova, A.; Nedin, D. 2004: Problems in the surgical treatment of Crohn's disease and our experience Khirurgiia 60(2): 4-10
Danese, S.; Sans, M.; Scaldaferri, F.; Sgambato, A.; Rutella, S.; Cittadini, A.; Piqué, J.M.; Panes, J.; Katz, J.A.; Gasbarrini, A.; Fiocchi, C. 2006: TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease Journal of Immunology 176(4): 2617-2624
Korelitz, B.I.; Adler, D.J.; Mendelsohn, R.A.; Sacknoff, A.L. 1993: Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease American Journal of Gastroenterology 88(8): 1198-1205
Sebastiani, M.; Beluffi, L.; Lungarotti, F.; Sensini, A. 1978: Reflections on ten years' experience in the treatment of hemorrhagic colorectitis and Crohn's disease Chirurgia Italiana 30(6): 765-772